期刊文献+

An Association between Immunosenescence and CD4^+CD25^+ Regulatory T Cells: A Systematic Review 被引量:10

An Association between Immunosenescence and CD^4+CD25^+ Regulatory T Cells: A Systematic Review
下载PDF
导出
摘要 Objective Age-related increment of the prevalence of CD4^+CD25^+ regulatory T (Treg) cells were described controversially, and whether such changes explain immune dysfunction in the elderly is still unclear. The aim of this systematic review is to evaluate the role of the Tregs in immunosenescence. Methods Medline and manual searches were performed to identify all published epidemiological and animal studies investigating the efficacy of the association between immunosenescence and Treg cells. Results It was founded that the frequency, phenotypic characteristics, and number/function of Tregs were altered significantly with aging. Medical conditions in individuals with advanced ageas well as apoptosis intensity of Treg cells had an impact on the accumulation of Tregs which in turn could deteriorate cytotoxic activity of CD8+ T and NK cells and production of IL-2. The range of immune cells that could be suppressed by Treg cells was quite wide and covered CD4^+CD25^+ T cells, NK cells, dendritic cells and even monocytes. These changes were observed both in humans and experimental animals. Besides, it was believed that frequency of Tregs increased with age and was accompanied by intensified suppressive activity for Tregs in patients, for example, with Alzheimer disease (AD) and Parkinson disease (PD). The impaired condition of CD4+ T cells, so-called immunosenescence, rendered transplant recipients less responsive to an allogeneic kidney graft, an effect that was limited to transplant recipients who were aged over 60 years. Conclusions Treg cells are associated with immunosenescence. All these changes contribute to the aging-related decline of immune responses and lead to the higher risk of immune-mediated diseases, cancer or infections in aged individuals. Objective Age-related increment of the prevalence of CD4^+CD25^+ regulatory T (Treg) cells were described controversially, and whether such changes explain immune dysfunction in the elderly is still unclear. The aim of this systematic review is to evaluate the role of the Tregs in immunosenescence. Methods Medline and manual searches were performed to identify all published epidemiological and animal studies investigating the efficacy of the association between immunosenescence and Treg cells. Results It was founded that the frequency, phenotypic characteristics, and number/function of Tregs were altered significantly with aging. Medical conditions in individuals with advanced ageas well as apoptosis intensity of Treg cells had an impact on the accumulation of Tregs which in turn could deteriorate cytotoxic activity of CD8+ T and NK cells and production of IL-2. The range of immune cells that could be suppressed by Treg cells was quite wide and covered CD4^+CD25^+ T cells, NK cells, dendritic cells and even monocytes. These changes were observed both in humans and experimental animals. Besides, it was believed that frequency of Tregs increased with age and was accompanied by intensified suppressive activity for Tregs in patients, for example, with Alzheimer disease (AD) and Parkinson disease (PD). The impaired condition of CD4+ T cells, so-called immunosenescence, rendered transplant recipients less responsive to an allogeneic kidney graft, an effect that was limited to transplant recipients who were aged over 60 years. Conclusions Treg cells are associated with immunosenescence. All these changes contribute to the aging-related decline of immune responses and lead to the higher risk of immune-mediated diseases, cancer or infections in aged individuals.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2010年第4期327-332,共6页 生物医学与环境科学(英文版)
基金 supported by the National Natural Science Foundation of China (No.30330540) the Jiangsu Provincial Fund for Clinical Immunology Key Laboratory (No.200319) the Scientific and Technological Fund to Support Project of Suzhou City (ZS0901)
关键词 Aging IMMUNOSENESCENCE CD4^+CD25^+ T cell Treg Case-control studies Cohort studies Cross-sectional studies Aging Immunosenescence CD4^+CD25^+ T cell Treg Case-control studies Cohort studies Cross-sectional studies
  • 相关文献

参考文献25

  • 1Pawelec G (1999). Immunosenescence: impact in the young as well as the old ? Mech Ageing Dev 108(1 ), 1-7.
  • 2Pawelec G, Koch S, Franceschi C, et al. (2006). Human ce: does it have an infectious component? Ann NYAcad Sei 1067, 56-65.
  • 3Hakim F T, Flomerfelt F A, Boyiadzis M, et al. (2004). Aging, immunity and cancer. Curr Opin lmmunol 16(2), 151-156.
  • 4Aw D, Silva A B, Palmer D B (2007). Immunosenescence: emerging challenges for an ageing population. Immunology 120(4). 435-446.
  • 5Kovaiou R D, Grubeck-Loebenstein B (2006). Age-associated changes within CD4-T cells, lmmunol Lett 107(1), 8-14.
  • 6Baecher-Allan C, Brown J A, Freeman G J, et al. (2001). CD4+CD25 high regulatory cells in human peripheral blood. J lmmunol 167(3), 1245-1253.
  • 7Tsaknaridis L, Spencer L, Culbertson N, et al. (2003). Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 74(2), 296-308.
  • 8Bryl E, Witkowski J M (2004). Decreased proliferative capability of CD4^+ cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells. Experimental Gerontology 39(4), 587-595.
  • 9Gregg R, Smith C M, Clark F J, et al. (2005). The number of human peripheral blood CD4+CD25^high regulatory T cells increases with age. Clinical and Experimental Immunology 1411(3), 540-546.
  • 10Trzonkowski P, Szmit E, Mysliwska J, et al. (2006). CD4+CD25+ T regulatory cells inhibit cytotoxie activity of CTL and NK cells in humans-impact of Clinical Immunology 119(3), 307-316.

同被引文献25

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部